Cardlytics shares surge 18.79% intraday as annual loss narrows 45.33% and Bridg platform asset sale finalizes.

Cardlytics surged 18.79% intraday trading, driven by a 45.33% reduction in full-year 2025 losses to $10.35 million, a January 2026 final agreement to sell Bridg platform assets (focusing on core banking operations), and analysts' $2.25 12-month target price implying 136.89% upside potential.